verified SJR 1,307 · Q1 • database Scopus / SJR & Web of Science indexed

Netherlands · Springer Science and Busines...

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Clinical and Experimental Metastasis

Clinical and Experimental Metastasis is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 112. It has an SJR impact factor of 1,307 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,307.

ISSN: 0262-0898

Publisher: Springer Science and Business Media B.V.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,307 Q1

H-index 112

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,307

H-index

112

Docs (year)

Docs 3y

165

Total refs

4893

Cites 3y

607

Citable 3y

148

Cites/Doc 2y

3.82

Ref/Doc

60.41

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Platelet fibronectin release induced by Walker 256 rat carcinoma tumor cells

Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice

Late abstracts 186-187

Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies

Melanoma invasion in reconstructed human skin is influenced by skin cells -investigation of the role of proteolytic enzymes

Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation

Oncogene expression in related cancer lines differing in metastatic capacity

p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases

Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan

SHOW MORE ARTICLES

Preferential growth of metastatic tumors at the pleural surface of mouse lung

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study

Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis

Roles for neuregulins in human cancer

Sentinel node tumor burden in prediction of prognosis in melanoma patients

Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients

The first international urokinase/warfarin trial in colorectal cancer

Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence

Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice

Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis

Effect of catechins and citrus flavonoids on invasionin vitro

A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence

FAQs

Clinical and Experimental Metastasis has an SJR of 1,307 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Clinical and Experimental Metastasis is 24%.

Clinical and Experimental Metastasis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Clinical and Experimental Metastasis?

What is the APC / publication cost?

What is the acceptance rate?